Disease
|
Drug/Important Bio-Agent (IBA)
3 | Proteins (Proteins, Gene)FDA Link
07/2010
-
01/2008 |
2 | Antineoplastic Agents (Antineoplastics)IBA
07/2010
-
11/2008 |
2 | LigandsIBA
11/2008
-
01/2008 |
1 | erucylphosphohomocholine ErPC3IBA
07/2010 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
07/2010 |
1 | erucylphospho- N,N,N- trimethylpropylammoniumIBA
07/2010 |
1 | N,N- di- n- hexyl- 2- (4- fluorophenyl)indole- 3- acetamideIBA
11/2008 |
1 | GABA-A Receptors (GABA(A) Receptor)IBA
11/2008 |
1 | Voltage-Dependent Anion ChannelsIBA
01/2008 |
1 | 5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
01/2008 |
1 | Mitochondrial Permeability Transition PoreIBA
01/2008 |
1 | Adenine NucleotidesIBA
01/2008 |
1 | Coloring Agents (Dyes)IBA
01/2008 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2008 |
1 | Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2008 |
1 | PK 11195 (PK11195)IBA
01/2008 |
|
Therapy/Procedure
|